Views | |
---|---|
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 206 |
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 1 | 0 | 1 | 7 | 3 | 0 | 0 |
Views | |
---|---|
art_3A10.1186_2Fs13195-016-0189-7.pdf | 161 |